Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

被引:49
作者
Duarte-Garcia, Ali [1 ,2 ]
Leung, Ying Ying [9 ]
Coates, Laura C. [10 ,11 ]
Beaton, Dorcas [14 ,15 ,16 ,17 ]
Christensen, Robin [22 ,23 ,24 ]
Craig, Ethan T. [3 ]
de Wit, Maarten [25 ]
Eder, Lihi [29 ]
Fallon, Lara [21 ]
FitzGerald, Oliver [26 ,27 ]
Gladman, Dafna D. [18 ]
Goel, Niti [4 ,30 ]
Holland, Richard [28 ]
Lindsay, Chris [5 ]
Maxwell, Lara [19 ,31 ]
Mease, Philip [6 ,7 ]
Orbai, Ana Maria [8 ]
Shea, Beverley [20 ,32 ]
Strand, Vibeke
Veale, Douglas J. [33 ,34 ]
Tillett, William [12 ,13 ]
Ogdie, Alexis [3 ]
机构
[1] Mayo Clin, Div Rheumatol, Dept Med, Rochester, MN USA
[2] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA
[3] Univ Penn, Dept Med, Div Rheumatol, Philadelphia, PA 19104 USA
[4] Kezar Life Sci, San Francisco, CA USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
[6] Swedish Providence St Johns Hlth Syst, Seattle, WA USA
[7] Univ Washington, Seattle, WA 98195 USA
[8] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA
[9] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore
[10] Univ Leeds, Leeds, W Yorkshire, England
[11] Univ Oxford, Oxford, England
[12] Royal Natl Hosp Rheumat Dis, Bath, Avon, England
[13] Univ Bath, Bath, Avon, England
[14] Univ Toronto, Musculoskeletal Hlth & Outcomes Res, St Michaels Hosp, Toronto, ON, Canada
[15] Univ Toronto, Inst Work & Hlth, Toronto, ON, Canada
[16] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Rehabil Sci Inst, Toronto, ON, Canada
[17] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[18] Univ Toronto, Dept Med, Toronto Western Hosp, Toronto, ON, Canada
[19] Univ Ottawa, Cochrane Musculoskeletal Grp, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada
[20] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada
[21] Pfizer Inc, Montreal, PQ, Canada
[22] Bispebjerg & Frederiksberg Hosp, Musculoskeletal Stat Unit, Copenhagen, Denmark
[23] Bispebjerg & Frederiksberg Hosp, Parker Inst, Copenhagen, Denmark
[24] Odense Univ Hosp, Dept Rheurnatol, Odense, Denmark
[25] Univ Amsterdam, Med Ctr, Patient Res Partner, Dept Med Humanities, Amsterdam, Netherlands
[26] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
[27] Univ Coll Dublin, Conway Inst Biomol Res, Dublin, Ireland
[28] Royal Prince Alfred Hosp, Med Ctr, Sydney, NSW, Australia
[29] Univ Toronto, Womens Coll Hosp, Dept Med, Toronto, ON, Canada
[30] Duke Univ, Div Rheumatol, Patient Res Partner, Sch Med, Durham, NC USA
[31] Ottawa Hosp Res Inst, Ctr Practice Changing Res, Cochrane Musculoskeletal Grp, Ottawa, ON, Canada
[32] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[33] St Vincents Univ Hosp, Dublin, Ireland
[34] Univ Coll Dublin, Dublin, Ireland
基金
美国国家卫生研究院;
关键词
OMERACT; PSORIATIC ARTHRITIS; OUTCOMES MEASURES; CORE SET; RHEUMATOID-ARTHRITIS; GLOBAL ASSESSMENT; CLINICAL-TRIALS; RELIABILITY; PATIENT;
D O I
10.3899/jrheum.181089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The Psoriatic Arthritis (PsA) Core Domain Set for randomized controlled trials and longitudinal observational studies has recently been updated. The joint counts are central to the measurement of the peripheral arthritis component of the musculoskeletal (MSK) disease activity domain. We report the Outcome Measures in Rheumatology (OMERACT) 2018 meeting's approaches to seek endorsement of the 66/68 swollen and tender joint count (SJC66/TJC68) for inclusion in the PsA Core Outcome Measurement Set (COS). Methods. Using the OMERACT Filter 2.1 Instrument Selection Process, the SJC66/TJC68 was assessed for (1) domain match, (2) feasibility, (3) numerical sense (construct validity), and (4) discrimination (test retest reliability, longitudinal construct validity, sensitivity in clinical trials, and thresholds of meaning). A protocol was designed to assess the measurement properties of the SJC66/TJC68 joint count. The results were summarized in a Summary of Measurement Properties table developed by OMERACT. OMERACT members discussed and voted on whether the strength of the evidence supported that the SJC66/TJC68 had passed the OMERACT Filter as an outcome measurement instrument for the PsA COS. Results. OMERACT delegates endorsed the use of the SJC66/TJC68 for the measurement of the peripheral arthritis component of the MSK disease activity domain. Among patient research partners, 100% voted for a "green" endorsement, whereas among the group of other stakeholders, 88% voted for a "green" endorsement. Conclusion. The SJC66/TJC68 is the first fully endorsed outcome measurement instrument using the OMERACT Filter 2.1 and the first instrument fully endorsed within the PsA COS.
引用
收藏
页码:996 / 1005
页数:10
相关论文
共 27 条
[1]   Single-joint Assessment for the Evaluation of Intraarticular Treatment: Responsiveness and Discrimination of the Composite Change Index [J].
Aalbers, Caroline J. ;
Gerlag, Danielle M. ;
Vervoordeldonk, Margriet J. ;
Tak, Paul P. ;
Landewe, Robert B. .
JOURNAL OF RHEUMATOLOGY, 2015, 42 (09) :1672-1676
[2]   Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology [J].
Beaton, Dorcas E. ;
Maxwell, Lara J. ;
Shea, Beverley J. ;
Wells, George A. ;
Boers, Maarten ;
Grosskleg, Shawna ;
Bingham, Clifton O., III ;
Conaghan, Philip G. ;
D'Agostino, Maria Antonietta ;
de Wit, Maarten P. ;
Gossec, Laure ;
March, Lyn M. ;
Simon, Lee S. ;
Singh, Jasvinder A. ;
Strand, Vibeke ;
Tugwell, Peter .
JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) :1028-1035
[3]  
Boers M, THE OMERACT HDB
[4]   Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 [J].
Boers, Maarten ;
Kirwan, John R. ;
Wells, George ;
Beaton, Dorcas ;
Gossec, Laure ;
d'Agostino, Maria-Antonietta ;
Conaghan, Philip G. ;
Bingham, Clifton O., III ;
Brooks, Peter ;
Landewe, Robert ;
March, Lyn ;
Simon, Lee S. ;
Singh, Jasvinder A. ;
Strand, Vibeke ;
Tugwell, Peter .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2014, 67 (07) :745-753
[5]   International Multicenter Psoriasis and Psoriatic Arthritis Reliability Trial for the Assessment of Skin, Joints, Nails, and Dactylitis [J].
Chandran, Vinod ;
Gottlieb, Alice ;
Cook, Richard J. ;
Duffin, Kristina Callis ;
Garg, Amit ;
Helliwell, Philip ;
Kavanaugh, Arthur ;
Krueger, Gerald G. ;
Langley, Richard G. ;
Lynde, Charles ;
McHugh, Neil ;
Mease, Philip ;
Olivieri, Ignazio ;
Rahman, Proton ;
Rosen, Cheryl F. ;
Salvarani, Carlo ;
Thaci, Diamant ;
Toloza, Sergio M. A. ;
Wong, Maxine Yat Wing ;
Zhou, Qian M. ;
Gladman, Dafna D. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09) :1235-1242
[6]   ARTHRITIS ROUNDS (6) - ULNAR NERVE ENTRAPMENT IN RHEUMATOID ARTHRITIS - A CASE REPORT [J].
DEANDRADE, JR ;
CASAGRANDE, PA .
ARTHRITIS AND RHEUMATISM, 1965, 8 (02) :294-+
[7]  
DUARTEGARCIA A, 2018, ARTHRITIS RHEUMA S10, V70
[8]   Measuring Joint Involvement in Polyarticular Psoriatic Arthritis: An Introduction of Alternatives [J].
Englbrecht, M. ;
Wang, Y. ;
Ronneberger, M. ;
Manger, B. ;
Vastesaeger, N. ;
Veale, D. J. ;
Schett, G. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (07) :977-983
[9]   Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors [J].
Fransen, J. ;
Antoni, C. ;
Mease, P. J. ;
Uter, W. ;
Kavanaugh, A. ;
Kalden, J. R. ;
Van Riel, P. L. C. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (10) :1373-1378
[10]  
Gladman DD, 2007, J RHEUMATOL, V34, P1733